Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery

Cancer

Volumn 79, Issue 5, 1997, Pages 884-891

  Fujimoto, Shigeru ^a   Takahashi, Makoto ^a   Mutou, Takaaki ^a   Kobayashi, Kokuriki ^a   Toyosawa, Tadashi ^a   Isawa, Eiji ^a   Sumida, Megumi ^a   Ohkubo, Haruo ^a  

^a Social Ins Funabashi Ctrl Hospital   (Japan)

Author keywords

gastric carcinoma; intraperitoneal hyperthermic chemoperfusion; peritoneal carcinomatosis; survival

Indexed keywords

DIALYSIS FLUID; MITOMYCIN C; PICIBANIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHERMIC THERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; STOMACH CANCER;

CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM METASTASIS; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0031040248     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C     Document Type: Article

References (26)

1. Buchholtz TW, Welch CE, Malt RA. Clinical correlates of resectability and survival in gastric carcinoma. Ann Surg 1978; 188:711-5.
2. Kaibara N, Iitsuka Y, Kimura A, Kobayashi Y, Hirooka Y, Nishidoi H, et al. Relationship between area of serosal invasion and progress in patients with gastric carcinoma. Cancer 1987;60:136-9.
3. Shiu MH, Fortner JG. Intraperitoneal hyperthermic treatment of implantable peritoneal cancer in rats. Cancer Res 1980;40:4081-4.
4. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Cancer Res 1980;40:256-60.
5. Fujimoto S, Shrestha RD, Kokubun M, Ohta M, Takahashi M, Kobayashi K, et al. Intraperitoneal hyperthermic perfusion combined with surgery effective for gastric cancer patients with peritoneal seeding. Ann Surg 1988;208:36-41.
6. Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Takahashi M, et al. Clinical trial with surgery and intraperitoneal hyperthermic perfusion for peritoneal recurrence of gastrointestinal cancer. Cancer 1989;64:154-60.
7. Fujimoto S, Takahashi M, Kobayashi K, Nagano K, Kure M, Mutoh T, et al. Cytohistologic assessment of antitumor effects of intraperitoneal hyperthermic perfusion with mitomycin C for patients with gastric cancer with peritoneal metastasis. Cancer 1992; 70:2754-60.
8. Fujimoto S, Takahashi M, Kobayashi K, Kure M, Mutou T, Masaoka H, et al. Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis. Oncology 1993;50:338-43.
9. Japanese Research Society for Gastric Cancer. The general rules for the gastric cancer study in surgery and pathology. I. Clinical classification. Jpn J Surg 1981; 11:127-39.
10. Hermanek P, Sobin LH. TNM classification of malignant tumours. 4th edition. Geneva: Union Internationale Contre le Cancer (UICC), 1987:43-6.
11. Fujimoto S, Akao T, Itoh B, Koshizuka I, Koyano K, Kitsukawa Y, et al. Protracted oral chemotherapy with fluorinated pyrimidines as an adjuvant to surgical treatment for stomach cancer. Ann Surg 1977; 185:462-6.
12. Fujimoto S, Furue H, Kimura T, Kondo T, Orita K, Taguchi T, et al. Clinical outcome of postoperative adjuvant immunochemotherapy with Sizofiran for patients with resectable gastric cancer: a randomized controlled study. Eur J Cancer 1991;27:1114-8.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-81.
14. Okajima K, Yamada S. Surgical treatment of far-advanced gastric cancer. Jpn J Cancer Clin 1986;32:1203-9.
15. Yamada S, Takeda T, Matsumoto K. Prognostic analysis of malignant pleural and peritoneal effusions. Cancer 1983; 51:136-40.
16. Hahn GM. Potential for therapy of drugs and hyperthermia. Cancer Res 1979;39:2264-8.
17. Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, et al. Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: pharmacological studies. Cancer Res 1990;50:5790-4.
18. Fujimoto S, Shrestha RD, Kokubun M, Kobayashi K, Kiuchi S, Konno C, et al. Pharmacokinetic analysis of mitomycin C for intraperitoneal hyperthermic perfusion in patients with far-advanced or recurrent gastric cancer. Reg Cancer Treat 1989;2:198-202.
19. Jol C, Kuppen P, Leeflang PA, van Oosterom AT, Tjaden UR, de Bruijn EA. In vitro pharmacology of mitomycin C in human ovarian cancer. In: Taguchi T, Andrysek O, editors. New trends in cancer chemotherapy with mitomycin C. Amsterdam: Excerpta Medica, 1987:181-91.
20. Teicher BA, Kowal CD, Kennedy KA, Sartorelli AC. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells. Cancer Res 1981;41:1096-9.
21. Fujimoto S, Shrestha RD, Kobayashi K, Koike S, Kokubun M, Kiuchi S, et al. Combined treatment with surgery and intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastrointestinal cancer with peritoneal seeding. Acta Med Austriaca 1989; 16:76-80.
22. Sugarbaker PH, Landy D, Jaffe G, Pascal R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil and mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 1990; 65: 1495-501.
23. Sumida M, Isawa E, Kobayashi K, Inaba H, Fujimoto S. TNF-and endotoxin serum levels in cancer patients undergoing intraperitoneal hyperthermic perfusioin. Int J Hyperthermia 1996; 12:607-15.
24. Fujimoto S, Kobayashi K, Takahashi M, Konno C, Kokubun M, Ohta M, et al. Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia. Br J Cancer 1992; 65:33-6.
25. Gilly FN, Sayag AC, Carry PY, Braillon G, James I, Vollocha A, et al. Intraperitoneal chemohyperthermia: a new therapy in the treatment of peritoneal seeding. Int Surg 1991;76:164-7.
26. Kober F, Heiss A, Roka R. Grundlagen und Technik der intraperitonealen hyperthermen Chemoperfusion (IHCP): Erste Erfahrungen bei diffuser Carcinosis peritonei. Acta Chir Austriaca 1995; 27:87-9.